{"filing":{"accession_number":"0001477932-26-004357","cik":"0001474167","ticker":"COSM","company_name":"Cosmos Health Inc.","form":"8-K","filing_date":"2026-07-16","report_date":null,"primary_document":"cosm_8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1474167/000147793226004357/cosm_8k.htm"},"events":[{"id":18460,"run_id":16595,"accession_number":"0001477932-26-004357","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.97,"summary":"Cosmos Health held its 2026 Annual Meeting of Stockholders on July 15, 2026, where shareholders voted on four proposals: election of six directors, ratification of the independent auditor, approval of the 2026 Equity Omnibus Plan, and approval of Series B Preferred Stock designation and issuance. All four proposals passed with affirmative vote percentages ranging from 78.98% to 84.24%.","company_name":"Cosmos Health Inc.","ticker":"COSM","filing_date":"2026-07-16","form":"8-K","submitted_at":null,"items":[{"id":17274,"accession_number":"0001477932-26-004357","item_number":"5.02","item_title":"DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports the results of a stockholder vote at the 2026 Annual Meeting of Stockholders held on July 15, 2026, where six directors were elected to serve until the next Annual Meeting. Although filed under Item 5.02, the substance of the disclosure is the outcome of a shareholder election, which is the core event type for Item 5.07 (shareholder vote results). The filing explicitly cross-references Item 5.07, confirming that the principal event is the election results themselves.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"","ticker":null,"filing_date":""},{"id":17275,"accession_number":"0001477932-26-004357","item_number":"5.03","item_title":"AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This disclosure reports stockholder approval and implementation of a new class of preferred stock (Series B) following the 2026 Annual Meeting. While the issuance of preferred stock has capital structure implications, the filing focuses on the governance action—the stockholder vote and the resulting amendment to the articles of incorporation via certificate of designation. The material terms were previously disclosed in the proxy statement, and this Item 5.03 documents the formal amendment process rather than a new financing event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"","ticker":null,"filing_date":""},{"id":17276,"accession_number":"0001477932-26-004357","item_number":"5.07","item_title":"SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on July 15, 2026, filed under Item 5.07. The section presents final voting tallies for four proposals: director elections (six nominees), ratification of the independent auditor, approval of the 2026 Equity Omnibus Plan, and approval of Series B Preferred Stock designation and issuance. All proposals passed with affirmative percentages ranging from 78.98% to 84.24%, making this a material governance event affecting investor understanding of board composition and capital structure authorization.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":18461,"run_id":16595,"accession_number":"0001477932-26-004357","anchor_item_number":"3.03","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.72,"summary":"The company implemented material modifications to the rights of security holders through amendments to its articles of incorporation, as disclosed under Item 3.03 with substance incorporated by reference from Item 5.03. The specific nature of these modifications relates to governance-level changes affecting shareholder rights and protections.","company_name":"Cosmos Health Inc.","ticker":"COSM","filing_date":"2026-07-16","form":"8-K","submitted_at":null,"items":[{"id":17273,"accession_number":"0001477932-26-004357","item_number":"3.03","item_title":"MATERIAL MODIFICATIONS TO RIGHTS OF SECURITY HOLDERS.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.72,"reasoning":"Item 3.03 discloses material modifications to rights of security holders, with the substance incorporated by reference from Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Without access to the Item 5.03 details, the filing indicates a governance-level change affecting shareholder rights. This is material to investors as it alters the fundamental rights or protections of security holders, though the specific nature of the modification cannot be determined from this cross-reference alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":17273,"accession_number":"0001477932-26-004357","item_number":"3.03","item_title":"MATERIAL MODIFICATIONS TO RIGHTS OF SECURITY HOLDERS.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.72,"reasoning":"Item 3.03 discloses material modifications to rights of security holders, with the substance incorporated by reference from Item 5.03 (Amendments to Articles of Incorporation or Bylaws). Without access to the Item 5.03 details, the filing indicates a governance-level change affecting shareholder rights. This is material to investors as it alters the fundamental rights or protections of security holders, though the specific nature of the modification cannot be determined from this cross-reference alone.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"Cosmos Health Inc.","ticker":"COSM","filing_date":"2026-07-16"},{"id":17274,"accession_number":"0001477932-26-004357","item_number":"5.02","item_title":"DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure reports the results of a stockholder vote at the 2026 Annual Meeting of Stockholders held on July 15, 2026, where six directors were elected to serve until the next Annual Meeting. Although filed under Item 5.02, the substance of the disclosure is the outcome of a shareholder election, which is the core event type for Item 5.07 (shareholder vote results). The filing explicitly cross-references Item 5.07, confirming that the principal event is the election results themselves.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"Cosmos Health Inc.","ticker":"COSM","filing_date":"2026-07-16"},{"id":17275,"accession_number":"0001477932-26-004357","item_number":"5.03","item_title":"AMENDMENTS TO ARTICLES OF INCORPORATION OR BYLAWS; CHANGE IN FISCAL YEAR.","event_type":"governance_other","event_domain":"governance","is_material":true,"confidence":0.75,"reasoning":"This disclosure reports stockholder approval and implementation of a new class of preferred stock (Series B) following the 2026 Annual Meeting. While the issuance of preferred stock has capital structure implications, the filing focuses on the governance action—the stockholder vote and the resulting amendment to the articles of incorporation via certificate of designation. The material terms were previously disclosed in the proxy statement, and this Item 5.03 documents the formal amendment process rather than a new financing event.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"Cosmos Health Inc.","ticker":"COSM","filing_date":"2026-07-16"},{"id":17276,"accession_number":"0001477932-26-004357","item_number":"5.07","item_title":"SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder vote results from the 2026 Annual Meeting held on July 15, 2026, filed under Item 5.07. The section presents final voting tallies for four proposals: director elections (six nominees), ratification of the independent auditor, approval of the 2026 Equity Omnibus Plan, and approval of Series B Preferred Stock designation and issuance. All proposals passed with affirmative percentages ranging from 78.98% to 84.24%, making this a material governance event affecting investor understanding of board composition and capital structure authorization.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T20:36:47.237814+00:00","company_name":"Cosmos Health Inc.","ticker":"COSM","filing_date":"2026-07-16"}]}